Skip to Content

Press Releases

Reps. Arrington, Sewell, Ruiz, and Hudson Introduce Bipartisan Bill to Remove Barriers to Innovative Multi-Cancer Screening Technology for Medicare Beneficiaries

H.R. 8845, the Multi-Cancer Early Detection Screening Coverage Act would ensure prompt access to FDA-approved multi-cancer screening tests and fuel innovation in cancer screening

WASHINGTON - Today, U.S. Reps. Jodey Arrington (TX-19), Terri Sewell (AL-07), Raul Ruiz (CA-36), and Richard Hudson (NC-08) introduced H.R. 8845, the Multi-Cancer Early Detection Screening Coverage Act, legislation to ensure timely Medicare coverage of groundbreaking early cancer detection tests for our nation’s seniors.  The bipartisan legislation recognizes emerging advances in our nation’s fight against cancer by ensuring Medicare coverage for new, innovative tests that detect multiple types of cancer before symptoms develop.  

 

“Multi-cancer early detection is an incredible example of the US leading in medical innovation,” stated Rep. Arrington. “This type of screening has the potential to drastically improve quality of life for American cancer patients and their families, and early detection will save taxpayer dollars by treating cancer before it spreads. I am proud to support this legislation and pave the way for Medicare beneficiaries to access this life-changing technology.”

 

“Cancer survival rates are higher when detected early, but we are losing too many Americans to cancer simply because we do not catch it early enough. Too often, those who are most likely to be diagnosed at late stages are members of our most vulnerable communities: minority, economically fragile, and rural populations,” said Rep. Sewell, the bill’s lead sponsor. “Our transformative legislation will help ensure Medicare beneficiaries are able to benefit from breakthrough screening technologies. I look forward to working with my colleagues to modernize the Medicare coverage statute and ensure timely access to multi-cancer screening for beneficiaries.” 

 

“Detecting cancer early improves health outcomes and saves lives,” said lead Democratic sponsor from the Energy and Commerce Committee Dr. Raul Ruiz. “With innovative medical technologies, we can catch more cancers earlier than ever, but patients must be able to access these screenings. That’s why it’s very important for Medicare policy to keep pace with the development of multi-cancer screenings. I am glad to join my colleagues in introducing the Multi-Cancer Early Detection Screening Coverage Act of 2020 to modernize Medicare coverage so older Americans can access these screenings and improve their health outcomes.”

 

“Families are devastated by a cancer diagnosis and as the second leading cause of death in the United States, it happens all too often,” said lead Republican cosponsor from the Energy and Commerce Committee Rep. Richard Hudson. “By increasing access to multi-cancer early detection screening tests through Medicare, we can save lives in North Carolina and around the country by catching more cancers sooner and allowing treatments to begin before cancers reach late stages. As a member of the Health Subcommittee, I look forward to advancing this bipartisan legislation.”

 

“This year has exposed the inequities in our nation’s healthcare system, but we have known for some time that cancer has an outsized impact on communities of color,” said Gary A. Puckerin, PhD, President and CEO of NMQF. “We must be ready to take full advantage of new technologies that give us the chance to not only close the gap in cancer outcomes among racial and ethnic groups, but also reduce patient risk for everyone. New multi-cancer early detection tests hold that promise and this legislation is essential to helping us achieve it.”

 

“We know early detection of cancer saves lives,” said Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN). “By creating a pathway for Medicare to cover new, innovative, FDA-approved screening tests, this legislation would help provide more individuals with access to additional tools they and their providers can utilize to detect cancer at an earlier, more treatable stage.”

 

“Today marks the 35th anniversary of the Prevent Cancer Foundation and today we are thrilled to celebrate the introduction of this important bill aimed at providing access to tests that will save lives through the early detection of cancer,” said Carolyn R. “Bo” Aldigé, Founder and CEO of the Prevent Cancer Foundation.

 

“As a community health center serving on the front lines in a region that's predominantly people of color, we see first-hand the inequities that exist related to cancer diagnosis, treatment and outcomes," said Anthony Gardner, CEO of Alabama Regional Medical Services. "We know that late-stage cancer is extraordinarily deadly. This legislation will place another tool in our arsenal to detect cancer early when it is easiest to treat and survival is greatest."

 

“As the Chief Executive Officer of the Rural Health Medical Program, I see firsthand that the health of rural residents suffers because of where we live,” said Keshee Dozier-Smith, CEO of the Rural Health Medical Program. "The communities that we serve are underinsured and uninsured minorities that suffer from chronic health conditions, with cancer being one of the leading deaths that go undetected in rural communities in Alabama due to the lack of availability and affordability. Providing access to Multi-cancer Early Detection Screenings creates opportunities to make real progress in the individuals and families we serve sooner rather than later in closing this gap.”

 

The Multi-Cancer Early Detection Screening Coverage Act responds to a misalignment between advances in science and Medicare coverage by allowing for Medicare coverage of multi-cancer screening. It would:

  • Create the authority for CMS to cover blood-based multi-cancer early detection tests and future test methods (like urine or hair tests), once approved by the Food and Drug Administration (FDA). Congress has acted before to create coverage for other cancer screenings including mammography and colorectal screenings. 
  • Maintain CMS’ authority to use an evidence-based process to determine coverage parameters for these new tests.
  • State that these new tools will complement, not replace, existing screenings and coverage and cost sharing will not be impacted.

 

Under current law, Medicare coverage of preventive services is limited to circumstances in which Congress has explicitly authorized coverage or the U.S. Preventive Services Task Force recommends the service with a grade of A or B.  In the absence of this legislation, it could take several years after the FDA approval before Medicare beneficiaries could receive coverage for such tests. This bill would greatly reduce any such access delays for seniors while allowing CMS to use its evidence-based process to determine coverage. Accordingly, these new multi-cancer screening tools will complement existing screenings and dramatically improve our nation’s cancer early detection capabilities.

 

The Multi-Cancer Early Detection Screening Coverage Act has the support of a number of organizations, including the: National Minority Quality Forum (NMQF), American Cancer Society Cancer Action Network (ACS CAN), Prevent Cancer Foundation, Association of Community Cancer Centers, and Cancer Support Community.

 

Find the text of the Multi-Cancer Early Detection Screening Coverage Act here.